Patents by Inventor Howard V. Raff

Howard V. Raff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20230158081
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Application
    Filed: November 23, 2022
    Publication date: May 25, 2023
    Inventor: Howard V. Raff
  • EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20230139230
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Application
    Filed: April 22, 2022
    Publication date: May 4, 2023
    Inventor: Howard V. RAFF
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20230120350
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: September 20, 2022
    Publication date: April 20, 2023
    Inventors: Bryan Walser, Howard V. Raff
  • Egg protein formulations and methods of manufacture thereof
    Patent number: 11197896
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: December 14, 2021
    Assignee: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
    Inventor: Howard V. Raff
  • Manufacture of peanut formulations for oral desensitization
    Patent number: 11141352
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: October 12, 2021
    Assignee: Société des Produit Nestlé S.A.
    Inventors: Bryan Walser, Howard V. Raff
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20210052722
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: April 7, 2020
    Publication date: February 25, 2021
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Egg protein formulations and methods of manufacture thereof
    Patent number: 10918676
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: February 16, 2021
    Assignee: Aimmune Therapeutics, Inc.
    Inventor: Howard V. Raff
  • Peanut formulations and uses thereof
    Patent number: 10653773
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: May 19, 2020
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20200129378
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: June 26, 2019
    Publication date: April 30, 2020
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Peanut formulations and used thereof
    Patent number: 10512686
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: December 24, 2019
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Manufacture of peanut formulations for oral desensitization
    Patent number: 10449118
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: October 22, 2019
    Assignee: AIMMUNE THERAPEUTICS, INC.
    Inventors: Bryan Walser, Howard V. Raff
  • EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20190247444
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Inventor: Howard V. RAFF
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20190192652
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 27, 2019
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20190175723
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: August 23, 2018
    Publication date: June 13, 2019
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan WALSER, Howard V. RAFF
  • Peanut formulations and uses thereof
    Patent number: 10086068
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: October 2, 2018
    Assignee: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
    Publication number: 20180042816
    Abstract: The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
    Type: Application
    Filed: October 24, 2017
    Publication date: February 15, 2018
    Inventors: Bryan WALSER, Howard V. RAFF
  • PEANUT FORMULATIONS AND USES THEREOF
    Publication number: 20170021012
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Application
    Filed: September 26, 2016
    Publication date: January 26, 2017
    Applicant: Aimmune Therapeutics, Inc.
    Inventors: Bryan Walser, Howard V. Raff
  • Peanut formulations and uses thereof
    Patent number: 9492535
    Abstract: The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: November 15, 2016
    Assignee: AIMMUNE THERAPEUTICS, INC.
    Inventors: Bryan Walser, Howard V. Raff
  • EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20160051593
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Application
    Filed: August 25, 2015
    Publication date: February 25, 2016
    Inventor: Howard V. Raff
  • EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20160051639
    Abstract: The present technology relates generally to formulations comprising egg white protein, methods of manufacturing egg protein formulations and uses for egg protein formulations. In particular, several embodiments are directed to egg protein formulations for oral administration in immunotherapy of subjects affected by egg allergies.
    Type: Application
    Filed: August 25, 2015
    Publication date: February 25, 2016
    Inventor: Howard V. Raff